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Decreased calcium-sensing receptor expression in hyperplastic serum PTH levels ensures the maintenance of normal
parathyroid glands of uremic rats: Role of dietary phosphate. serum calcium levels. This tight control of calcium ho-
Background. The abnormal control of parathyroid hormone meostasis becomes abnormal in patients with primarysecretion in chronic renal failure is attributed, in part, to down-
hyperparathyroidism and patients with secondary hyper-regulation of the calcium-sensing receptor (CaR) in hyperplas-
parathyroidism caused by end-stage renal disease. Para-tic parathyroid tissue. The cause of this down-regulation is
unknown. Here we examined the roles of uremia and parathy- thyroid cells from these patients have been shown to
roid hyperplasia on parathyroid gland (PTG) CaR expression be less sensitive to calcium [2–10], although there are
in the rat model of renal failure. conflicting reports concerning an altered calcium re-
Methods. Rats made uremic by 5/6 nephrectomy were main-
sponse in vivo in the patients with secondary hyperpara-tained for one month on diets containing 0.2% P (low phos-
thyroidism [11–16]. The mechanism for this abnormalphate), 0.5% P (normal phosphate) or 1.2% P (high phosphate);
intact rats (controls) were maintained on the normal-phosphate response to calcium is not known, but recent studies by
diet. Kifor et al and Gogusev et al showing decreased CaR
Results. CaR mRNA was reduced only in uremic rats fed expression in PTGs of patients with primary and uremic
the high-phosphate diet (55% less than in controls, P , 0.05). secondary hyperparathyroidism may provide at least aImmunohistochemical staining revealed decreased CaR pro-
partial explanation [17, 18].tein expression in uremic high-phosphate rat PTG compared
Secondary hyperparathyroidism associated with chronicwith controls (41% decrease as determined by computer-as-
sisted quantitation, P , 0.01). PTG size was increased in uremic renal failure is characterized by hypersecretion of PTH
rats fed the high-phosphate diet compared with controls (2.77 6 and enlargement of the PTG. The pathogenesis of this
0.95 vs. 0.77 6 0.16 mg/g body wt, P , 0.0001). There was no disorder has been attributed to an increase in plasma phos-increase in PTG size in uremic rats fed the low-phosphate and
phorus and decreases in plasma calcium and 1,25(OH)2D3.normal-phosphate diets (0.92 6 0.31 and 1.01 6 0.31 mg/g)
Whether these or other factors are also responsible forcompared with controls (0.77 6 0.16 mg/g body wt). Immuno-
histochemical staining for proliferating cell nuclear antigen the decreased CaR expression in renal failure is not
in hyperplastic PTG from uremic rats showed that CaR was known.
decreased primarily in areas of active cell proliferation. Here we examined the roles of uremia and parathyroid
Conclusion. These results suggest that CaR down-regulation
hyperplasia (as controlled by dietary phosphate) on thecannot be attributed to uremia per se, but rather, is associated
expression of CaR mRNA and protein in rat PTGs. Wewith parathyroid cell proliferation. Furthermore, dietary phos-
found that (a) down-regulation of the CaR occurs inphate restriction prevents both the parathyroid hyperplasia
and decreased CaR expression in renal failure. chronic renal failure, but only when the PTGs are hyper-
plastic; (b) phosphate restriction prevents both parathy-
roid hyperplasia and decreased CaR in renal failure;
and (c) areas of decreased CaR protein expression areParathyroid glands (PTGs) express a calcium-sensing
associated with areas of parathyroid cell proliferation.receptor (CaR) that regulates the secretion of the calcio-
These findings demonstrate that the uremic rat providestropic hormone parathyroid hormone (PTH) [1]. The
a viable model to define the relationship between abnor-inverse relationship between extracellular calcium and
mal control of parathyroid cell growth and alterations
of CaR expression.
Key words: receptor, parathyroid hyperplasia, uremia, chronic renal
failure, diet, calcium homeostasis.
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volves ligation of most of the branches of the left renal PCR primers were 59-CGC CGC AGC AAC GTC TCC
CG-39 (sense) and 59-CGT AAC AGT GCT GCC TCCartery followed by right nephrectomy. The uremic rats
were maintained for one month on one of three diets: GC-39 (antisense). A TA cloning kit (In Vitrogen, San
Diego, CA, USA) was used to clone the PCR product(a) a low-phosphate diet (LP; 0.2% P, 0.5% Ca, N 5 7),
(b) a normal-phosphate diet (NP; 0.5% P, 0.9% Ca, into the pCR II vector. Sequence analysis of the 552 bp
cDNA for rat CaR revealed 80% homology with theN 5 6), or (c) a high-phosphate diet (HP; 1.2% P, 0.4%
Ca, N 5 7). This HP diet was used to enhance the degree bovine CaR [21] at the amino acid level and differed by
only six bases from the recently published sequence ofof parathyroid hyperplasia. A group of intact rats (con-
trols) was maintained on the NP diet. After one month, the rat kidney CaR [22]. The cDNA insert was subcloned
into the EcoR I site of Bluescript KS1 (Stratagene, Sanblood was drawn by aortic puncture for clinical determi-
nations, and the animals were sacrificed by exsanguina- Diego, CA, USA). Radiolabeled antisense RNA was
produced with T7 RNA polymerase and [a-32P]CTP. Ation. Using microsurgical techniques, the PTGs were im-
mediately removed for analysis as described below. Only riboprobe for rat b-actin was made using T7 RNA poly-
merase and a reverse transcriptase-PCR cDNA clonedanimals from which a pair of PTGs was removed were
used in the study. From each PTG pair, one gland was into pCR II. The sizes of the riboprobes and protected
fragments were 595 and 552 for CaR and 280 and 250used for analysis of CaR mRNA by a ribonuclease pro-
tection assay and the other for the measurement of CaR for b-actin.
The ribonuclease protection assay was performed asprotein by immunohistochemical staining. Diets were
obtained from Dyets Inc. (Bethlehem, PA, USA). The previously described by our laboratory [23]. Briefly,
RNA from each PTG pair was mixed with the 32P-labeledAnimal Studies Committee of Washington University
approved all animal protocols. riboprobes for CaR and b-actin. After hybridization at
458C for 16 hours, the samples were digested with ribo-
Clinical determinations nuclease T-1 and then with proteinase K. The protected
RNA fragments were extracted with phenol-chloroform,Plasma ionized calcium was measured using a specified
electrode (Model ICA-1; Radiometer, Copenhagen, precipitated with ethanol, and resolved on a 5% poly-
acrylamide gel. The gel was dried, and the bands wereDenmark). Plasma creatinine and phosphorus were de-
termined by an auto analyzer (COBAS MIRA Plus, quantitated using a phosphorimager (Model 445; Molec-
ular Dynamics, Sunnyvale, CA, USA). CaR mRNA wasBranchburg, NJ, USA). Serum PTH was measured by
an immunoradiometric assay specific for intact rat PTH normalized to b-actin mRNA.
(Nichols Institute, San Capistrano, CA, USA). PTGs
Development and characterization of thewere weighed on a microbalance (CAHN C-31; CAHN
calcium-sensing receptor antibodyInstruments, Inc., Cerritos, CA, USA), and results were
reported as a ratio of gland weight per body weight. A polyclonal antibody against a 23-amino acid peptide
(ADDDYGRPGIEKFREEAEERDIC) contained in the1,25(OH)2D3 was extracted from serum according to the
method of Hollis [19] and was measured as described extracellular domain of the CaR that is conserved in hu-
man, bovine, and rat was developed in rabbit (Researchby Reinhardt et al [20].
Genetics, Huntsville, AL, USA). The antiserum was passed
Measurement of calcium-sensing receptor mRNA by over protein G-sepharose (Pharmacia Biotech, Uppsala,
ribonuclease protection assay Sweden), and the IgG fraction was eluted per manufac-
turer’s directions. The IgG fraction was used as the pri-Calcium-sensing receptor mRNA in rat PTGs was
analyzed using a ribonuclease protection assay. PTGs mary antibody. Nonspecific staining (negative control)
was obtained by substituting rabbit preimmune IgG forwere transferred to a microfuge tube containing 250 ml
RNAzole B (Tel-Test, Inc., Friendswood, TX, USA) the primary antibody; preimmune IgG was purified from
preimmune serum as described above.for isolation of total RNA. The tubes were immediately
frozen in liquid nitrogen and stored at 2808C. Just prior Specificity of the primary antibody for the CaR was
assessed by Western blot analysis using rat parathyroidto analysis, the contents of the tubes were thawed on
ice, and the PTGs were homogenized using a plastic tissue. Parathyroid glands were removed from intact,
normal rats and were homogenized with a plastic pestlepestle. Total RNA was isolated as directed by the manu-
facturer of the RNAzole B. into cold lysis/sample buffer [62.5 mm Tris, pH 6.8, 10%
glycerol, 1% sodium dodecyl sulfate (SDS), 0.05% brom-A cDNA for rat CaR was produced by reverse tran-
scriptase-polymerase chain reaction (PCR) with the use phenol blue, and 50 mm dithiothreitol]. This homogenate
was sonicated on ice for one minute. Proteins were sepa-of rat PTG RNA and primers from the portion of the
bovine CaR cDNA from base pairs 3196 to 3762 of the rated by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) using 4 to 20% Tris-glycine gelspublished bovine sequence [21] that codes for the
COOH-terminal cytoplasmic tail of the protein. The (Fisher Scientific, Pittsburgh, PA, USA) and then trans-
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ferred to Hybonde ECLe nitrocellulose membranes were calculated as a percentage of optical densities ob-
(Amersham Life Science Inc., Arlington Heights, IL, tained from control animals. When additional tissue sec-
USA). The membranes were blocked at 48C for one hour tions from an animal were stained, they were run with
with phosphate buffered saline (PBS) containing 0.1% different controls. The percentages obtained for any one
Tween-20 and 5% nonfat dry milk. The membranes were animal on different days of staining were then averaged,
then incubated overnight at 48C with 5 mg/ml of the resulting in a single value per animal. Student’s unpaired
primary antibody or preimmune IgG. The membranes t-test was used for statistical evaluation.
were incubated with anti-rabbit secondary antibody con- Immunohistochemical staining of the CaR protein was
jugated to horseradish peroxidase for one hour and were quantitated using a Nikon Diaphot-TMD microscope
then developed with a Phototopet-HRP Western detec- coupled to a camera and an image analysis system. Im-
tion kit (both obtained from New England Biolabs Inc., ages of stained tissue sections (magnification 3100) were
Beverly MA, USA). Phosphate-buffered saline con- acquired using a DAGE-330 color camera and were cap-
taining 0.1% Tween-20 was used to wash the membranes tured with a Pentium P-166 IBM-compatible computer
after incubations with the first and second antibodies. equipped with a Coreco frame grabber. The digitized
images were converted to gray scale and analyzed using
Measurement of calcium-sensing receptor protein by
Image-Pro Plus software (Media Cybernetics, Silver
immunohistochemical staining
Spring, MD, USA). All components were obtained from
Specificity of the primary antibody for the CaR was Boyce Scientific, Inc. (St. Louis, MO, USA). A compre-
further assessed by immunohistochemical staining of rat hensive discussion of quantitative immunohistochemical
PTG tissue in which primary antibody was substituted staining using computer image analysis can be found in
with (a) preimmune IgG, or (b) primary antibody that Mize’s study [24]. The threshold calibration was as fol-
had been preabsorbed by an equal amount (wt/wt) of lows: An average gray value obtained from a blank area
the peptide against which it was raised. of a slide (no tissue) was used as maximal incident light;
Calcium-sensing receptor protein in the rat PTGs was minimal light (the black value) was set as 0, and an
assessed by immunohistochemical staining and quanti- average gray value (minus two standard deviations) ob-
tated by computer-assisted image analysis. Immunohis- tained from the negative control tissue was used to set
tochemical staining was performed on formalin-fixed, the level of the lowest detectable intensity of staining.
paraffin-embedded parathyroid glands using our primary When the threshold is calibrated in this manner, the
antibody and a commercial immunohistochemical stain- lowest level of detectable staining is set at a point that
ing kit (Histostain-Plus, rabbit; Zymed Laboratories, is slightly darker than the staining of the negative control
Inc., South San Francisco, CA, USA). Every precaution
tissue. The intensity of staining of the CaR was then
was taken to minimize the degree of variability on each
quantitated using the optical density function of the soft-day of immunostaining. Antibody incubations, washes,
ware. The average optical density per section of tissuestaining times, etc., were kept constant for all samples
was calculated by dividing the sum integrated opticalassayed together. Because the staining of each sample
density by the sum area. It should be stressed that onlywas compared with the staining of the controls (normal
pixels containing an intensity of staining that fell withinrats) run on that day, day-to-day variations were not a
the set threshold were used for calculating the opticalconcern. (This is described in more detail later in this
density and area. Therefore, pixels containing an inten-article.) Briefly, the tissue was deparaffinized, rehydrated,
sity of staining that fell outside of this threshold wereand endogenous peroxidase quenched using 0.6% hydro-
automatically excluded from the calculations by the soft-gen peroxide in methanol. Tissue was blocked with 10%
ware program (that is, tissue that stained the same inten-preimmune goat serum and incubated with primary anti-
sity as the negative control or any nonstaining areas suchbody (6.4 mg/ml) or preimmune IgG (6.4 mg/ml) for one
fibrous tissue or holes in the tissue were not considered inhour at room temperature. Biotinylated secondary anti-
the calculations). To eliminate variation, the microscopebody was applied followed by a streptavidin-horseradish
light source intensity used during image capture was keptperoxidase conjugate. The immune complexes were visu-
constant for all sections stained on any one day.alized with aminoethyl carbazole (AEC) substrate-chro-
To test the hypothesis that the sites of parathyroidmagen. Approximately 20 consecutive sections of tissue
cell proliferation correspond to areas of decreased CaRwere cut from each PTG. A total of 8.4 6 2.0 of these
expression, consecutive sections of hyperplastic PTGssections per PTG was immunostained over a two- to
were immunostained for the CaR and for proliferativethree-day period. On each day of immunostaining, tissue
cell nuclear antigen (PCNA), a protein that is foundsections from two to three animals per experimental
in the nucleus of dividing cells. A mouse anti-PCNAgroup were analyzed together. The optical densities of
antibody (Zymed Laboratories, Inc.) was used for immu-the staining intensities (obtained as described later here)
from each of the animals in the LP, NP, and HP groups nohistochemical staining of PCNA.
Brown et al: Decreased CaR in uremic rats 1287
Table 1. Serum chemistries
Creatinine ICa P
PTH PTG/Body wt
Group mg/dl pg/ml lg/g
Controls (N 5 7) 0.760.0 4.5860.09 4.4960.58 2063 0.7760.16
Uremic LP (N 5 7) 1.4460.49c 4.5860.21 4.2660.54 27 65c 0.9260.31
Uremic NP (N 5 6) 1.2560.10a 4.5260.25 5.0861.11 29 69d 1.0160.31
Uremic HP (N 5 7) 1.4460.21a 3.7860.48b 13.9163.85a 5816209a 2.7760.95a
Data are mean 6 sd.
Compared to control values: aP , 0.0001; bP , 0.001; cP , 0.01; dP , 0.05
RESULTS greater in the uremic rats fed the HP diet (UHP), the
CaR mRNA/b-actin ratio is less in this group comparedCalcium-sensing receptor mRNA expression
with the same ratio in the N, ULP, and UNP groups. ToCalcium-sensing receptor mRNA expression was eval-
show that the decrease in CaR mRNA was not simplyuated in control rats fed an NP diet and in nephrecto-
due to phosphate, both control and uremic rats weremized rats maintained on an LP, NP, or HP diet for one
maintained on an HP diet (0.9% P, 0.6% Ca) in a separatemonth. Blood chemistries are summarized in Table 1.
experiment. Compared with control rats, the PTGs ofAll groups of nephrectomized rats developed uremia as
the uremic rats became hyperplastic (0.85 6 0.10 vs. 1.59indicated by increases in serum creatinine levels com-
6 0.31 mg/g body wt, P . 0.0001) and exhibited a 50%pared with controls [0.7 6 0.0 mg/dl in control rats vs.
decrease in CaR mRNA (P , 0.05). Overall, these results1.44 6 0.49 in LP uremic rats (P , 0.01), 1.25 6 0.10 in
suggest that a decrease in CaR expression is associatedNP uremic rats (P , 0.0001), and 1.44 6 0.21 mg/dl in
with parathyroid cell proliferation rather than uremia orHP uremic rats (P , 0.001)]. The group of uremic rats
dietary phosphate alone.fed the HP diet exhibited a 29-fold increase in PTH (20 6
3 vs. 581 6 209 pg/ml, P , 0.0001) and a 3.6-fold increase Specificity of calcium-sensing receptor antibody
in PTG weight (0.77 6 0.16 vs. 2.77 6 0.95 mg/g body
The specificity of the primary antibody for rat parathy-wt, P , 0.0001) compared with controls. Denda et al
roid CaR was assessed by Western blot, as illustrated inhave previously shown that this parathyroid enlargement
Figure 2. Molecular weight markers are shown in laneseen in rats uremic for this length of time is the result
1. In the presence of primary antibody (lane 2), twoof hyperplasia rather than hypertrophy [25]. Importantly,
predominant bands representing glycosylated CaR re-the groups of uremic rats fed the LP or NP diets showed
ceptor at approximately 150 to 165 kDa were detected.no change in PTG weight compared with controls; how-
The fainter bands most likely represent products of deg-ever, they exhibited a slight, although significant, in-
radation. Previous reports have shown that CaR proteincrease in PTH [20 6 3 pg/ml in control rats vs. 27 6 5
size ranges from approximately 130 to 160 kDa and isin LP uremic rats (P , 0.01) and 29 6 9 pg/ml in NP
represented by either multiple bands or one broad banduremic rats (P , 0.05)]. Compared with controls, the
[17, 26–28]. No CaR protein was detected with preim-uremic rats fed the HP diet exhibited a significant in-
mune IgG (lane 3) or with primary antibody preabsorbedcrease in serum phosphorus levels (4.49 6 0.58 vs. 13.91 6
with immunizing peptide (data not shown).3.85 mg/dl, P , 0.0001) and a significant decrease in
Specificity of the primary antibody for CaR was fur-serum-ionized calcium levels (4.58 6 0.09 vs. 3.78 6 0.48,
ther assessed in immunohistochemical staining of consec-P , 0.001), although no difference was seen in levels of
utive sections of rat PTG tissue, as shown in Figure 3.serum 1,25(OH)2D3 levels (56.3 6 21.0 vs. 55.0 6 17.3
As opposed to strong staining seen with primary anti-pg/ml for controls and uremic HP rats, respectively). The
body (Fig. 3B), replacing the primary antibody with anphosphorus and calcium levels in the LP and NP uremic
equivalent concentration of preimmune IgG (Fig. 3A)rats were no different from control values.
or with primary antibody that had been preabsorbedThe expression of CaR mRNA in PTGs from control
with the peptide against which it was raised (Fig. 3C)and uremic rats fed LP, NP, or HP diets was assessed
resulted in no cellular staining.by ribonuclease protection assay. As shown in Figure
1A, CaR mRNA was significantly reduced only in PTGs
Calcium-sensing receptor protein expressionfrom uremic rats maintained on the HP diet (55% less
To further investigate the observed decrease in CaRthan controls, P , 0.05). An autoradiogram of a ribo-
expression in rat hyperplastic PTGs, we examined CaRnuclease protection assay, in which pooled samples from
protein using immunohistochemical staining in controlthis experiment were run, is shown in Figure 1B. Al-
though the intensity of the CaR mRNA band appears rats fed an NP diet and in uremic rats maintained on an
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Fig. 2. Western blot showing specificity of the anti-CaR primary anti-
body for rat parathyroid CaR protein. (1) Molecular weight markers.
(2) Primary antibody (immune IgG). (3) Preimmune IgG.
seen in only the groups of uremic rats fed the HP diet
(41% decrease compared with controls, P , 0.01). This is
in agreement with the observed decrease in CaR mRNA.
Representative photomicrographs of immunostained
sections of PTGs from all groups are shown in Figure 4.
In the uremic rats fed the HP diet (UHP), there appeared
to be both an overall decrease in staining and a heteroge-
neous staining compared with the other groups, which
tended to be more homogeneous in appearance. This
decrease in PTG CaR protein expression was also ob-
served in a separate experiment in which nephrecto-
mized rats were maintained on a HP diet (1.2% P, 0.4%
Ca) for one month. The PTGs of these uremic rats be-
came hyperplastic (0.99 6 0.31 vs. 2.29 6 0.15 mg/g body
wt for normal and uremic rats, respectively, P , 0.0001)
and showed a 54% decrease (P , 0.0001) in immunohis-
tochemical staining of the CaR compared with controls
(intact rats maintained on 0.8% P, 0.8% Ca).
Immunohistochemical staining of PCNA and CaR in
consecutive sections of a hyperplastic PTG from a uremicFig. 1. Calcium-sensing receptor (CaR) mRNA levels in rat parathy-
rat is shown in Figure 5. Note the heterogeneous stainingroid glands. (A) Uremic rats were fed a low-phosphate (ULP), normal-
phosphate (UNP), or high-phosphate (UHP) diet for one month; intact of the CaR protein (Fig. 5A); the less intense staining
rats (control) were maintained on the NP diet. CaR mRNA was ana- of the CaR in the upper portion of the gland correspondslyzed using a ribonuclease protection assay and was normalized to
well with the punctate staining of PCNA seen in theb-actin mRNA. Values expressed as mean 6 sd (N 5 7 each for
controls, LP and HP; N 5 6 for NP, *P , 0.05). (B) Ribonuclease upper portion of the next section of the gland (Fig. 5B).
protection assay autoradiogram of pooled samples from the experiment
When normal (nonproliferating) rat PTGs were stainedillustrated in (A).
for both proteins, the tissue stained intensely for the
CaR, but only an occasional (0 to 4) PCNA-positive
nuclei per gland section was detected (data not shown).
This suggests that areas of active cell proliferation areLP, NP, or HP diet for one month. The degree of staining
associated with areas of reduced expression of CaR. Theintensity was quantitated by computer-assisted image
same relationship between CaR and PCNA staining wasanalysis and was reported as optical density. Results of
observed in hyperplastic parathyroid tissue from humanthe image analysis of CaR immunohistochemical staining
patients with primary and secondary hyperparathyroid-in the four experimental groups are shown in Table 2.
A significant decrease in CaR protein expression was ism (unpublished observations).
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Table 2. Immunohistochemical staining quantitation
Optical density
Group % controls
Controls (N 5 7) 100.0626.9
Uremic LP (N 5 7) 98.7626.4
Uremic NP (N 5 6) 147.2691.5
Uremic HP (N 5 7) 58.8613.1a
Immunohistochemical staining of the CaR was quantified by computer-
assisted image analysis and data expressed as percent of controls (mean 6 sd).
a P , 0.01 compared to controls
Fig. 3. Specificity of the anti-calcium–sensing receptor primary anti-
body for rat parathyroid calcium-sensing receptor (CaR) protein. Photo-
Fig. 4. Calcium-sensing receptor (CaR) protein expression in parathy-micrographs of immunohistochemical staining of the CaR in consecutive
roid glands of normal and uremic rats. Representative photomicro-sections of a normal rat parathyroid tissue incubated with (B) primary
graphs of immunohistochemical staining of the CaR in parathyroidantibody (immune IgG), (A) preimmune IgG, and (C) primary antibody
tissue of uremic rats fed a low-phosphate diet (ULP), a normal-phos-preabsorbed with the antigen against which it was raised. Magnification
phate diet (UNP), and a high-phosphate diet (UHP) for one month;3100. Publication of this figure in color was made possible by a grant
control rats (N) were maintained on the NP diet. Magnification 3100.from Genzyme Corporation, Cambridge, MA, USA.
Publication of this figure in color was made possible by a grant from
Genzyme Corporation, Cambridge, MA, USA.
DISCUSSION
In this study, we demonstrate that expression of both tissue from normal controls and uremic rats. These re-
CaR mRNA and protein is decreased in hyperplastic sults are in agreement with those of previous studies of
human parathyroid tissue. Kifor et al showed a substan-PTGs from uremic rats compared with nonhyperplastic
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Fig. 5. A comparison of CaR and proliferating cell nuclear antigen (PCNA) protein expression in hyperplastic rat parathyroid tissue. Immunohisto-
chemical staining of (A) CaR and (B) PCNA in consecutive sections of hyperplastic parathyroid tissue from a uremic rat. Magnification 3100.
Publication of this figure in color was made possible by a grant from Genzyme Corporation, Cambridge, MA, USA.
tial decrease in the intensity of immunohistochemical are not fully understood. We have previously shown that
CaR mRNA is decreased in hyperplastic glands fromstaining of CaR protein in parathyroid adenomas and
parathyroid tissue from renal failure patients with severe vitamin D-deficient rats and that 1,25-(OH)2D3 up-regu-
lates CaR mRNA in PTGs and kidneys of normal ratssecondary hyperparathyroidism compared with normal
parathyroid tissue from patients with adenomas [17]. [23]. However, in this study, the levels of 1,25(OH)2D3
levels were not decreased in the uremic rats with reducedThese findings were supported by Gogusev et al who
showed that the expression of CaR mRNA and protein CaR expression. Therefore, low 1,25(OH)2D3 did not
appear to be a factor in producing down-regulation ofwas reduced in most cases of primary adenoma and sec-
ondary hyperplasia compared with strong expression in CaR expression in hyperplastic PTGs of uremic rats in
this study.normal parathyroid tissue, as determined by in situ hybrid-
ization and immunohistochemical staining techniques Our findings also exclude a role for uremic toxins in
the reduction of CaR expression. Although uremic rats[18]. In parathyroid tissue from renal failure patients,
they found that the expression of both CaR mRNA and fed the LP, NP, or HP diets had similar degrees of renal
insufficiency, the expression of parathyroid CaR was sig-protein was often depressed to a greater degree in nodu-
lar areas compared with adjacent diffuse hyperplasia. nificantly decreased in only those maintained on the HP
diet; this suggests that uremia per se is not responsibleWhether this difference was due to a higher rate of cell
proliferation was not clear. In this study, we found a for the changes seen in the expression of the CaR. We
also found that the only rats to develop parathyroiddecrease in expression of the CaR in hyperplastic PTGs
in rats with renal failure. Uremic rats on diets that did not hyperplasia were those fed the HP diet. Results of a
separate experiment, however, suggested that phosphatepromote parathyroid hyperplasia showed no significant
CaR down-regulation. alone was not responsible for the decrease in CaR ex-
pression in hyperplastic PTGs.The factors responsible for this decrease in CaR ex-
pression in primary and secondary hyperparathyroidism Overall, our results suggest that the decreased CaR
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expression in uremic rat PTGs is associated with cell prolif- rat model will prove useful in addressing this problem,
which would be difficult, if not impossible, to addresseration rather than uremia or phosphate alone. A study
by Rogers et al showed that parathyroid CaR expression in chronic renal failure patients. Also of interest is the
functional significance of decreased CaR expression inwas unchanged in rats with secondary hyperparathyroid-
ism induced by 5/6 nephrectomy [29]. In addition, Her- the parathyroid. Kifor et al and Gogusev et al have
shown decreased CaR expression in PTGs from patientsnandez et al showed that secondary hyperparathyroidism
(when induced by a high-phosphate diet in both normal with primary and secondary hyperparathyroidism [17,
18]. It is known that parathyroid cells from patients withand uremic rats) is not associated with changes in CaR
expression in the PTG [30]. There may be several expla- primary hyperparathyroidism are less responsive to sup-
pression of PTH secretion by extracellular calcium bothnations for the differences between the results of these
two studies and the results in this study. One explanation in vivo [2, 3] and in vitro [4–8]. A similar abnormal
response to calcium has been observed in vitro in para-could be the techniques used to analyze CaR expression.
The ribonuclease protection assay used in our study may thyroid cells from patients with secondary hyperparathy-
roidism [7, 9, 10]. However, a controversy exists concern-have been more sensitive than the Northern blot analysis
used in the latter study. In addition, neither of the previ- ing an altered calcium response in vivo in these patients
[11–16]. Whether the decreased expression of the CaRous studies used immunohistochemical staining tech-
niques to detect changes in CaR protein [29, 30]. Also, in hyperplastic PTGs is associated with abnormal sensing
of calcium by these glands in vivo and how this wouldwe found a 29-fold increase in serum PTH in the uremic
rats that exhibited a decrease in parathyroid CaR expres- affect the expression of PTH remain to be determined.
Here we demonstrate that the uremic rat provides asion; the increases in serum PTH in uremic rats in the
other two studies were much less pronounced (fourfold viable model to help define the relationship between
abnormal control of parathyroid cell growth and alter-and sevenfold increases) [29, 30]. Furthermore, we found
a 3.6-fold increase in PTG weight, whereas neither of the ations of CaR expression.
other studies measured PTG weight. Therefore, the de-
gree of parathyroid hyperplasia may have been greater in ACKNOWLEDGMENTS
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